Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 185

Similar articles for PubMed (Select 19433458)

1.
4.

The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice.

Reilly CM, Thomas M, Gogal R Jr, Olgun S, Santo A, Sodhi R, Samy ET, Peng SL, Gilkeson GS, Mishra N.

J Autoimmun. 2008 Sep;31(2):123-30. doi: 10.1016/j.jaut.2008.04.020. Epub 2008 Jul 23.

PMID:
18650065
5.

B7RP-1 blockade ameliorates autoimmunity through regulation of follicular helper T cells.

Hu YL, Metz DP, Chung J, Siu G, Zhang M.

J Immunol. 2009 Feb 1;182(3):1421-8.

6.

Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.

Sobel ES, Brusko TM, Butfiloski EJ, Hou W, Li S, Cuda CM, Abid AN, Reeves WH, Morel L.

Arthritis Res Ther. 2011 Jun 27;13(3):R106. doi: 10.1186/ar3387.

7.

Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus.

Simpson N, Gatenby PA, Wilson A, Malik S, Fulcher DA, Tangye SG, Manku H, Vyse TJ, Roncador G, Huttley GA, Goodnow CC, Vinuesa CG, Cook MC.

Arthritis Rheum. 2010 Jan;62(1):234-44. doi: 10.1002/art.25032.

8.

The pathology of T cells in systemic lupus erythematosus.

Mak A, Kow NY.

J Immunol Res. 2014;2014:419029. doi: 10.1155/2014/419029. Epub 2014 Apr 23. Review.

9.

HOZOTs, novel human regulatory T-cell lines, exhibit helper or suppressor activities depending on dendritic cell or anti-CD3 stimulation.

Sugimoto A, Suzuki M, Otani T, Okochi A, Takeuchi M, Yamasaki F, Nakamura S, Kibata M.

Exp Hematol. 2009 Dec;37(12):1454-63. doi: 10.1016/j.exphem.2009.10.002. Epub 2009 Oct 9.

PMID:
19819295
10.

The role of CD4CD25 T cells in autoantibody production in murine lupus.

Hsu WT, Suen JL, Chiang BL.

Clin Exp Immunol. 2006 Sep;145(3):513-9.

12.

Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 response.

Waters B, Qadura M, Burnett E, Chegeni R, Labelle A, Thompson P, Hough C, Lillicrap D.

Blood. 2009 Jan 1;113(1):193-203. doi: 10.1182/blood-2008-04-151597. Epub 2008 Sep 24.

13.

Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.

Liang B, Gardner DB, Griswold DE, Bugelski PJ, Song XY.

Immunology. 2006 Nov;119(3):296-305.

15.

Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.

Sasaki N, Yamashita T, Takeda M, Shinohara M, Nakajima K, Tawa H, Usui T, Hirata K.

Circulation. 2009 Nov 17;120(20):1996-2005. doi: 10.1161/CIRCULATIONAHA.109.863431. Epub 2009 Nov 2.

16.

Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus.

Iikuni N, Lourenço EV, Hahn BH, La Cava A.

J Immunol. 2009 Aug 1;183(3):1518-22. doi: 10.4049/jimmunol.0901163. Epub 2009 Jul 1.

17.
18.

Increased CD45RA+ FoxP3(low) regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus.

Pan X, Yuan X, Zheng Y, Wang W, Shan J, Lin F, Jiang G, Yang YH, Wang D, Xu D, Shen L.

PLoS One. 2012;7(4):e34662. doi: 10.1371/journal.pone.0034662. Epub 2012 Apr 10.

19.

ANTI-CD3 therapy expands the numbers of CD4+ and CD8+ Treg cells and induces sustained amelioration of collagen-induced arthritis.

Notley CA, McCann FE, Inglis JJ, Williams RO.

Arthritis Rheum. 2010 Jan;62(1):171-8. doi: 10.1002/art.25058.

20.

Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients.

Hahn BH, Anderson M, Le E, La Cava A.

Arthritis Rheum. 2008 Aug;58(8):2488-97. doi: 10.1002/art.23609.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk